Trial Profile
Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Tipifarnib (Primary) ; Topotecan (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 31 Aug 2005 New trial record.